Prolonged delay for controlling KPC-2–producing Klebsiella pneumoniae outbreak: The role of clinical management
| Autor: | Anne Carbonne, C. Goulenok, I. Novakova, G. Antoniotti, S. Boyer, Thierry Naas, E. Seringe, Tristan Delory, I. Paysant, Pascal Astagneau |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
Time Factors Epidemiology Disease cluster beta-Lactamases Disease Outbreaks Tertiary Care Centers Risk Factors Health care Disease Transmission Infectious Humans Medicine Infection control Safety culture Intensive care medicine Risk management Cross Infection Infection Control business.industry Transmission (medicine) Health Policy Public Health Environmental and Occupational Health Outbreak Klebsiella Infections Klebsiella pneumoniae Infectious Diseases business Root cause analysis |
| Zdroj: | American Journal of Infection Control. 43:1070-1075 |
| ISSN: | 0196-6553 |
| Popis: | Background Carbapenemase-producing Enterobacteriaceae (CPE) are becoming of immediate concern for infection control policies. Prompt detection of CPE on health care setting admission is crucial to halt the spread of an outbreak. We report a cluster of 13 Klebsiella pneumoniae carbapenemase (KPC)-2–producing K pneumoniae cases in a tertiary care hospital.The objective of this study was to identify contributing factors originating the outbreak. Methods An outbreak investigation was conducted using descriptive epidemiology, observation of health care practices, and interviews of management staff. A root cause analysis was performed to identify patent and latent failures of infection control measures using the association of litigation and risk management method. Results The main patent failure was the delay in identifying KPC-2–producing K pneumoniae carriers. Contributing factors were work and environmental factors: understaffing, lack of predefined protocols, staff members' characteristics, and underlying patients' characteristics. Latent failures were as follows: no promotion of the national guidelines for prevention of CPE transmission, no clear procedure for the management of patients hospitalized abroad, no clear initiative for promoting a culture of quality in the hospital, biologic activity recently outsourced to a private laboratory, and poor communication among hospital members. Conclusion Clinical management should be better promoted to control hospital outbreaks and should include team work and safety culture. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect